Orangewood Partners

The firm is led by Alan Goldfarb and Neil Goldfarb, who appear as the listed principals on the Orangewood website. Both are supported by a team of 14 other investment and operations staff, along with an external Operating Partner Group of six named individuals, but the specific governance or investment committee structure is not publicly detailed by the firm.

Orangewood deploys capital through buyouts and growth equity, and it states a preference for control, 50/50 partnerships, and structured minority equity. This flexibility allows the firm to tailor transactions to each opportunity, whether acquiring a founder's stake or partnering alongside an existing management team.

The firm targets equity checks from $25 million to over $100 million, a range it applies consistently across its buyout and growth equity strategies. This places the firm firmly in the North American mid-market, well above most individual-backed searches and below the minimums set by large-cap private equity funds.

All disclosed activity points to direct deal-making only. Orangewood's website lists 11 portfolio companies across current and realized investments — all of which are operating businesses in which the firm has taken an equity stake, with no mention of commitments to external private equity funds.

Orangewood has not published a formal exclusions list, but its portfolio and stated focus areas suggest a deliberate avoidance of technology, biotech, and heavy industry. The firm concentrates on consumer services, business services, real estate, and health and wellness, with current exposure exclusively in franchised service brands, healthcare delivery, and specialty finance.

There is no publicly available evidence that Orangewood Partners operates a philanthropic foundation or manages charitable assets as part of its investment activities. The firm's website does not mention any related donor-advised funds, grant-making entities, or impact-investing carve-outs.

Orangewood has not disclosed a formal co-investment program, but its strategy of 50/50 partnerships and structured minority equity suggests a willingness to share boardrooms with other capital providers. Any co-investment opportunities would likely arise on a deal-by-deal basis, though the firm has not publicized specific examples of syndicating a position with other institutional investors.